Janine Senz

Author PubWeight™ 77.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009 18.08
2 ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010 13.07
3 Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009 5.63
4 deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput Biol 2011 4.66
5 SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 2010 4.02
6 Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007 3.62
7 Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas. J Pathol 2011 2.64
8 Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J Pathol 2013 2.35
9 Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 2011 2.25
10 Type-specific cell line models for type-specific ovarian cancer research. PLoS One 2013 1.73
11 Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas. J Pathol 2013 1.47
12 Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005 1.46
13 Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 2008 1.45
14 Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009 1.39
15 Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009 1.21
16 MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS One 2009 1.18
17 Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2009 1.13
18 BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma. Mod Pathol 2012 1.12
19 The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors. PLoS One 2009 1.07
20 Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer 2008 1.06
21 FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 2011 1.01
22 Using next-generation sequencing for the diagnosis of rare disorders: a family with retinitis pigmentosa and skeletal abnormalities. J Pathol 2011 0.94
23 FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Mod Pathol 2013 0.90
24 beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer. Genes Chromosomes Cancer 2005 0.89
25 Mutation discovery in regions of segmental cancer genome amplifications with CoNAn-SNV: a mixture model for next generation sequencing of tumors. PLoS One 2012 0.79
26 [Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]. Acta Gastroenterol Latinoam 2007 0.78
27 Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma. Int J Gynecol Cancer 2015 0.76
28 Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research. PLoS One 2013 0.76
29 FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors. Am J Surg Pathol 2015 0.75
30 Mechanisms of monozygotic (MZ) twinning: a possible role for the cell adhesion molecule, E-cadherin. Am J Med Genet A 2003 0.75